Cannabidiol (CBD), this molecule extracted from cannabis that many people would like to understand and tame, seems to have a loose back when it comes to stating its effects on health. Despite the non-euphoric nature attributed to CBD, some data could suggest that it confers a notable level of psychotropic effects, provided that certain parameters are respected. Dose? Route of administration? Specific product formulation? Complex to know… Are the products sold on the regulated market in Quebec likely to create such a detectable effect? A very relevant question from a public health point of view. Ultimately, what does CBD do to our body? And how can you be sure? Here is an effective strategy to answer it: conduct clinical studies.

The project's description

The Didier Jutras-Aswad research laboratory aims to find a person to carry out a doctoral project as part of a clinical study whose main objective is to verify whether low doses of CBD, as sold on the regulated market, possess the ability to generate a noticeable subjective response when consumed via inhalation. The project also offers the possibility of verifying the effect of low doses of CBD on a plethora of parameters related to mental health and human physiology. This is seminal work to better understand the effect of CBD products in a context of non-therapeutic consumption, making it possible to guide consumption choices based on evidence.

Qualifications

• Master's degree in biomedical sciences, psychiatry, neuroscience, psychology, or other relevant discipline;
• Be motivated and have experience in clinical research in the field of psychiatry, substance use or a related field; 
• Strong interest in working on cannabis consumption; 
• Strong skills in quantitative analysis methods; 
• Ability to seek scholarships for graduate studies; 
• Good knowledge of French (an asset) and English; 
• Excellent writing and communication skills.
   

Competitive benefits 

• Full time position, 35 hours per week
• Schedule flexibility
• Start date: as soon as possible
• Duration: 3 to 5 years
• The position will be based at the Research Center of the University of Montreal Hospital Center (CRCHUM)
• Dynamic research environment: You will work in a scientific and professional setting with a multidisciplinary team including experts in nursing, neuroscience, biology, psychology, mental health and addiction intervention, and psychiatry
• Collaborations and support: Teamwork is valued to guarantee high quality in project execution. The laboratory promotes the working context allowing you to contribute to the scientific literature, by supporting publication in peer-reviewed journals and by encouraging presentations at international level conferencesà
• Financial security: Thanks to research funds, the laboratory provides financial support to our student community, with in return an obligation to apply for various scholarship programs, thus offering a range of solutions to ensure the financial security of those registered in the program. doctorate among us
• Professional development: The diversity of projects makes it possible to broaden scientific horizons and perfect knowledge in different complementary fields, conferring a clear advantage on the job market and in the academic environment.

To apply

Interested candidates must send by email a curriculum vitae, a cover letter, relevant transcripts and the contact details of two people who can act as references to:
 francois-olivier.hebert.chum@ssss.gouv.qc.ca

It is “essential” to attach your CV for your application to be considered.

We thank everyone who applies, but will only contact those selected for a test or interview.

The CRCHUM invites women, Indigenous people, visible minorities, ethnic minorities and people with limitations to submit their applications. The CRCHUM adopts a broad and inclusive definition of diversity that goes beyond applicable laws.

The CRCHUM therefore encourages all people, regardless of their characteristics, to apply. In accordance with Canadian immigration requirements, please note that priority will be given to Canadian citizens and permanent residents